FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Knowing when to invest rather than save can significantly enhance your financial growth. This guide provides insights to help you decide wisely.
26,010 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
Oil approaching $100 per barrel could upend retail economics. Walmart appears best positioned to weather an energy-dr...
Two century-old dividend histories anchor a growing conversation about reliable income in today’s volatile markets. Y...
Trump Media & Technology Group pivots from traditional media toward a Bitcoin treasury, with 2025 revenue of $3.7 mil...
Peter Thiel's hedge fund sold Nvidia shares and shifted into Microsoft and Apple, signaling a strategic pivot in AI b...
A Guggenheim note argues Oracle's near-term cash burn from AI infrastructure will flip to a strong free cash flow wat...
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
A wave of battlefield tech is migrating into everyday products, creating new bets for investors as 2026 markets ride ...
A broader AI software sell-off created a rare opportunity for long-term investors. Here are three blue-chip options t...
Tech shares rebound as AI demand supports earnings. This report highlights the best tech stocks right now, detailing ...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...